Targeting colloidal particulates to thoracic lymph nodes.

[1]  Elke S. Bergmann-Leitner,et al.  Editorial [Hot Topic: Anti-Cancer Drugs Executive Editor: Elke Bergmann-Leitner] , 2005 .

[2]  M. Liptay.  Sentinel node mapping in lung cancer , 2004, Annals of Surgical Oncology.

[3]  Rakesh K Jain,et al.  Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.

[4]  S. Hyon,et al.  An Experimental Study of Regional Chemotherapy Using CDDP-Loaded Microspheres for Esophageal Cancer , 2002, Surgery Today.

[5]  S. Feng,et al.  Fabrication, characterization and in vitro release of paclitaxel (Taxol) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[6]  C. Porter,et al.  Intestinal lymphatic drug transport: an update. , 2001, Advanced drug delivery reviews.

[7]  G. Storm,et al.  Liposomes to target the lymphatics by subcutaneous administration. , 2001, Advanced drug delivery reviews.

[8]  C. Sakakura,et al.  Intraperitoneal injection of dextran sulfate as an anti-adherent drug for the prevention of peritoneal metastasis of cancer shows low toxicity in animals , 2000, Anti-cancer drugs.

[9]  Jim Moselhy,et al.  In vitro studies of the interaction of poly(NIPAm/MAA) nanoparticles with proteins and cells , 2000, Journal of biomaterials science. Polymer edition.

[10]  M. Johnston,et al.  Characterization of a highly metastatic, orthotopic lung cancer model in the nude rat , 1999, Clinical & Experimental Metastasis.

[11]  H. Shinohara.  Distribution of lymphatic stomata on the pleural surface of the thoracic cavity and the surface topography of the pleural mesothelium in the golden hamster , 1997, The Anatomical record.

[12]  C. Sakakura,et al.  Selective drug delivery to peri-tumoral region and regional lymphatics by local injection of aclarubicin adsorbed on activated carbon particles in patients with breast cancer—a pilot study , 1997, Anti-cancer drugs.

[13]  Lisbeth Illum,et al.  Preparation of Biodegradable, Surface Engineered PLGA Nanospheres with Enhanced Lymphatic Drainage and Lymph Node Uptake , 1997, Pharmaceutical Research.

[14]  H. Yoshikawa,et al.  Lymphotropic delivery of cyclosporin A by intramuscular injection of biodegradable microspheres in mice. , 1996, Biological & pharmaceutical bulletin.

[15]  N. Saitō,et al.  [Evaluation of endoscopic pirarubicin-Lipiodol emulsion injection therapy for gastric cancer]. , 1996, Gan to kagaku ryoho. Cancer & chemotherapy.

[16]  C. Porter,et al.  Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion. , 1996, Journal of pharmaceutical sciences.

[17]  S. Davis,et al.  Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics , 1995 .

[18]  X. Wu,et al.  Preparation and Characterization of Thermal- and pH-Sensitive Nanospheres , 1993, Pharmaceutical Research.

[19]  V. Stella,et al.  Lymphatic Transport of Drugs , 1992 .

[20]  T. Tadakuma,et al.  The antitumor effects of adriamycin entrapped in liposomes on lymph node metastases , 1990, The Japanese journal of surgery.

[21]  Skinner Db.  Choices in treating carcinoma of the esophagus. , 1989 .

[22]  A. Hagiwara,et al.  Anticancer agents adsorbed by activated carbon particles, a new form of dosage enhancing efficacy on lymphnodal metastases. , 1986, Anticancer research.

[23]  S. Sieber,et al.  Enhanced lymph node uptake of melphalan following liposomal entrapment and effects on lymph node metastasis in rats. , 1982, Cancer treatment reports.

[24]  V. Budker,et al.  Intralymphatic administration of liposome-encapsulated drugs to mice: possibility for suppression of the growth of tumor metastases in the lymph nodes. , 1981, Journal of the National Cancer Institute.

[25]  I. Fidler,et al.  The pathogenesis of cancer metastasis , 1980, Nature.

[26]  U. Bettendorf.  Electronmicroscopic studies on the peritoneal resorption of intraperitoneally injected latex particles via the diaphragmatic lymphatics. , 1979, Lymphology.

[27]  L. Leak.  STUDIES ON THE PERMEABILITY OF LYMPHATIC CAPILLARIES , 1971, The Journal of cell biology.

[28]  L. Leak.  Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. , 1970, Microvascular research.

[29]  L. Medina,et al.  Pharmacokinetics and biodistribution of [111In]-avidin and [99mTc]-biotin-liposomes injected in the pleural space for the targeting of mediastinal nodes. , 2004, Nuclear medicine and biology.

[30]  T. Godfrey,et al.  Prognostic significance of micrometastasis in non-small-cell lung cancer. , 2004, Clinical lung cancer.

[31]  Christopher J.H. Porter.  Drug delivery to the lymphatic system. , 1997, Critical reviews in therapeutic drug carrier systems.

[32]  S. P. Vyas,et al.  A lymphotropic colloidal carrier system for diethylcarbamazine: preparation and performance evaluation. , 1994, Journal of microencapsulation.

[33]  R. Pelton.  Polystyrene and polystyrene‐butadiene latexes stabilized by poly(N‐isopropylacrylamide) , 1988 .